Michael G. Silverman

Author

Also Known As

Daniel S. Newman, M G Silverman, Marat Slessarev, Michael G Silverman, Michael G. Silverman, Michael Gordon Silverman, Michael Silverman

Publications

10.7K

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Brigham and Women's Hospital Johns Hopkins University Johns Hopkins Medicine Baptist Hospital of Miami

About

Michael G. Silverman is an author at Massachusetts General Hospital specializing in medicine, cardiovascular disease, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	929
2	Public Health	8	8	371
3	Health Sciences	3	3	305
4	Natural Sciences	1	1	66
5	Cell Biology	1	1	66

Michael G. Silverman

Publications

8.4K

Citations

H-Index

Page 1

	Year	Citations
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca, New England Journal of Medicine	2018	6K
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus Eri Kato, Michael G. Silverman, Ofri Mosenzon, Circulation	2019	550
Use of Coronary Artery Calcium Testing to Guide Aspirin Utilization for Primary Prevention: Estimates From the Multi-Ethnic Study of Atherosclerosis Michael D. Miedema, Daniel Duprez, Jeffrey R. Misialek, Circulation Cardiovascular Quality and Outcomes	2014	235
The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA) Mahmoud Al Rifai, Michael G. Silverman, Khurram Nasir, Atherosclerosis ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver Disease	2015	204
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca, American Heart Journal Metabolic SyndromeHypertensionCardiovascular DiseaseDapagliflozin EffectPharmacology	2018	179
Mir-30d Regulates Cardiac Remodeling by Intracellular and Paracrine Signaling Jin Li, Ane Salvador, Guoping Li, Circulation Research	2020	167
lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth Haobo Li, Lena Trager, Xiaojun Liu, Circulation	2022	112
Association of Coronary Artery Calcium and Coronary Heart Disease Events in Young and Elderly Participants in the Multi-Ethnic Study of Atherosclerosis Rajesh Tota-Maharaj, Michael J. Blaha, Ron Blankstein, Mayo Clinic Proceedings Vascular DiseaseCoronary Artery CalciumCardiovascular EpidemiologyCardiovascular DiseaseMedicine	2014	110
<scp>DECLARE‐TIMI</scp> 58: Participants’ baseline characteristics Itamar Raz, Ofri Mosenzon, Marc P. Bonaca, Diabetes Obesity and Metabolism	2018	108
Relation of Uric Acid to Serum Levels of High-Sensitivity C-Reactive Protein, Triglycerides, and High-Density Lipoprotein Cholesterol and to Hepatic Steatosis Tanya E. Keenan, Michael J. Blaha, Khurram Nasir, The American Journal of Cardiology Metabolic SyndromeLipid DisorderUrologyHepatologyMedicine	2012	87

Page 1